OLIG2 Recombinant Antibody, Cy5 Conjugated
Product Specifications
Background
Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain. Functions together with ZNF488 to promote oligodendrocyte differentiation. Cooperates with OLIG1 to establish the pMN domain of the embryonic neural tube. Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development.
Synonyms
Oligo2; bHLHb1; Class E basic helix-loop-helix protein 19; bHLHe19; OLIG2; BHLHB1; BHLHE19; PRKC.
Gene ID
10215
Swiss Prot
Q13516
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
OLIG2
Clonality
Recombinant
Conjugation
Cy5
Source
KLH conjugated synthetic peptide derived from human Oligo2
Applications
WB, IF
Purification
Purified by Protein A.
Excitation Emission
625,650nm/670nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
10215
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
586939-01 10 µg
Interleukin-1 beta, Active, Recombinant, Human, aa117-269 (IL1B) discontinued
Ask
View Details 
586939-02 50 µg
Interleukin-1 beta, Active, Recombinant, Human, aa117-269 (IL1B) discontinued
Ask
View Details 